| Income Statement | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Loss from operations | -6,799 | -13,515 | -4,632 | |
| Other income, net | 157 | 53 | 110 | |
| Interest expense | -29 | -31 | -8 | |
| Total other income, net | 128 | 22 | 102 | |
| Loss before income taxes | -6,671 | -13,493 | -4,530 | |
| Net loss | -6,671 | -13,493 | -4,530 | |
| Basic eps | -0.26 | -0.98 | -0.36 | |
| Diluted eps | -0.26 | -0.98 | -0.36 | |
| Basic average shares | 25,694,000 | 13,714,000 | 12,870,000 | |
| Diluted average shares | 25,694,000 | 13,714,000 | 12,870,000 | |
Oncocyte Corp (OCX)
Oncocyte Corp (OCX)